Asia-Pacific Americas Africa Europe Middle East

GLENMARK LIFE SCIENCE LIMITED

Company Profile:

GLENMARK LIFE SCIENCE LIMITED Company Introduction

GLENMARK LIFE SCIENCE LIMITED is a factory.

Company Introduction:

Glenmark Life Science Limited is a leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs). The company focuses on the development, manufacturing, and marketing of high-quality APIs, including those for chronic therapeutic areas such as cardiovascular disease, central nervous system disorders, pain management, and anti-infectives. It is a subsidiary of Glenmark Pharmaceuticals Limited, with a strong emphasis on research and development to create a diverse portfolio of complex and niche APIs. Glenmark Life Science operates multiple manufacturing facilities that are approved by major regulatory bodies worldwide, supplying pharmaceutical companies globally.

Enterprise Products

Glenmark Life Sciences Limited primarily focuses on the development and manufacturing of Active Pharmaceutical Ingredients APIs for various therapeutic areas. Their product portfolio includes a wide range of APIs, some of which are:

Anticancer APIs

Antidiabetic APIs

Antidepressant APIs

Antihistamine APIs

Antihypertensive APIs

Cardiovascular APIs

Central Nervous System CNS APIs

Gastrointestinal APIs

Anti-infective APIs

Anti-inflammatory APIs

Respiratory APIs

Dermatological APIs

Ophthalmological APIs

Specific examples of their APIs include:

Telmisartan

Rosuvastatin

Olmesartan

Perindopril

Rivaroxaban

Saxagliptin

Sitagliptin

Vildagliptin

Linezolid

Favipiravir

Montelukast

Finasteride

Dutasteride

Ezetimibe

Itraconazole

Voriconazole

Ciprofloxacin

Levofloxacin

Moxifloxacin

Amlodipine

Valsartan

Irbesartan

Losartan

Ramipril

Atorvastatin

Simvastatin

Pravastatin

Fluoxetine

Sertraline

Escitalopram

Paroxetine

Citalopram

Fexofenadine

Levocetirizine

Desloratadine

Betahistine

Pantoprazole

Rabeprazole

Esomeprazole

Omeprazole

Lansoprazole

Dabigatran Etexilate

Apixaban

Ticagrelor

Clopidogrel

Prasugrel

Tadalafil

Sildenafil

Vardenafil

Letrozole

Anastrozole

Exemestane

Tamoxifen

Bicalutamide

Flutamide

Nilutamide

Abiraterone Acetate

Enzalutamide

Pomalidomide

Lenalidomide

Daclatasvir

Sofosbuvir

Velpatasvir

Glecaprevir

Pibrentasvir

Ledipasvir

Voxilaprevir

Business Registration Information:

Manager:

Dr. Yasir Rawjee (Managing Director & Chief Executive Officer)

Phone:

+91 251 2623300

E-mail:

investorrelations@glenmarklifesciences.com

Official Website:
Address:

Plot No. S-7, H-6 & H-6/1, Phase II, MIDC, Ambernath (W), Dist. Thane, Maharashtra - 421 501, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.